PROSTATE CA
Clinical trials for PROSTATE CA explained in plain language.
Never miss a new study
Get alerted when new PROSTATE CA trials appear
Sign up with your email to follow new studies for PROSTATE CA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug cocktail could boost prostate cancer treatment before surgery
Disease control Recruiting nowThis study tests whether adding two drugs (fasudil hydrochloride and a PD1 inhibitor) to standard hormone therapy before prostate cancer surgery can improve outcomes. About 83 men with locally advanced or limited spread prostate cancer will participate. The goal is to see if this…
Matched conditions: PROSTATE CA
Phase: PHASE2, PHASE3 • Sponsor: baotai Liang • Aim: Disease control
Last updated May 22, 2026 14:03 UTC
-
New drug combo aims to shrink prostate tumors before surgery
Disease control Recruiting nowThis early-phase trial tests whether giving two drugs (darolutamide and relugolix) before prostate cancer surgery is safe and practical for men with high-risk prostate cancer. About 30 adult men will receive the drug combination for a short time before their prostate is removed. …
Matched conditions: PROSTATE CA
Phase: PHASE1 • Sponsor: AdventHealth • Aim: Disease control
Last updated May 22, 2026 14:01 UTC
-
Could a leukemia drug boost prostate cancer treatment?
Disease control Recruiting nowThis study tests whether adding the drug homoharringtonine to standard hormone therapy before prostate removal surgery can better shrink or eliminate tumors. About 96 men with locally advanced or limited metastatic prostate cancer will receive either the combo or hormone therapy …
Matched conditions: PROSTATE CA
Phase: PHASE2 • Sponsor: baotai Liang • Aim: Disease control
Last updated May 20, 2026 11:56 UTC
-
Could just two radiation doses beat five for prostate cancer?
Disease control Recruiting nowThis study tests if giving radiation in just 2 sessions works as well as the standard 5 sessions for men with intermediate-risk prostate cancer. The goal is to see if fewer treatments cause fewer side effects and are more convenient, while still controlling the cancer. All partic…
Matched conditions: PROSTATE CA
Phase: PHASE2 • Sponsor: British Columbia Cancer Agency • Aim: Disease control
Last updated May 18, 2026 12:11 UTC
-
New hope for men battling hot flashes from prostate cancer treatment
Symptom relief Recruiting nowThis study tests a drug called fezolinetant to reduce hot flashes in men with prostate cancer who are on hormone therapy. Hot flashes can be bothersome and affect daily life. The drug is already approved for hot flashes in menopausal women. About 32 men will take the drug daily f…
Matched conditions: PROSTATE CA
Phase: PHASE2 • Sponsor: University of Vermont • Aim: Symptom relief
Last updated May 07, 2026 18:41 UTC